methoxy polyethylene glycol epoetin beta
Selected indexed studies
- Epoetin Beta. (, 2006) [PMID:30277694]
- Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease. (Drugs, 2008) [PMID:18484803]
- Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure. (Expert Rev Hematol, 2016) [PMID:26573694]
_Worker-drafted node — pending editorial review._
Connections
methoxy polyethylene glycol epoetin beta is a side effect of
Sources
- Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease. (2008) pubmed
- Epoetin Beta. (2006) pubmed
- Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure. (2016) pubmed
- Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients. (2017) pubmed
- Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review. (2014) pubmed
- Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off? (2009) pubmed
- The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease. (2023) pubmed
- Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. (2023) pubmed
- Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial. (2025) pubmed
- Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease. (2012) pubmed